Nova Realidade Covid-19 após 1 ano

Opportunities ⚫ Despite the slowdown in the national drug market, Brazil remains attractive to new investors willing to take advantage of the strong. development opportunities arising from positive demographic trends, the incidence of non-infectious diseases and a still large portion of the unassisted population, mainly in the North and North East. • The preferred methods of entry are investments "in new areas" and the acquisition of local drug manufacturers that specialize in niche segments or that have offered products for sale at very low prices. 65 000 KPMG © 2021 KPMG Auditores Independentes, a Brazilian entity and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved. Printed in Brazil. BD210890 Page 111

View entire presentation